CompletedNot applicableNCT04182763
CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Studying Pantothenate kinase-associated neurodegeneration
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- Penelope Hogarth, M.D., MDOregon Health and Science University
- Intervention
- CoA-Z(other)
- Enrollment
- 77 enrolled
- Eligibility
- 89 years · All sexes
- Timeline
- 2019 – 2025
Study locations (1)
- Oregon Health & Science University, Portland, Oregon, United States
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Washington State University · Oregon State University · Spoonbill Foundation · Spoonbill
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04182763 on ClinicalTrials.gov